The word “patent” is referred from a Latin term “patere” which means “to lay open,” i.e. to make available for public inspection. There are three basic tests for any invention to be patentable: Firstly, the invention must be novel, meaning thereby that the Invention must not be in existence. Secondly, the Invention must be non- obvious, i.e. the Invention must be a significant improvement to the previous one; mere change in technology will not give the right of the patent to the inventor. Thirdly, the invention must be useful in a bonafide manner, meaning thereby that the Invention must not be solely used in any illegal work and is useful to the world in a bonafide manner.
The invention relates to a drug or dietary supplement for treatment and/or prophylaxis of diseases of the joints, in particular arthrosis, containing a collagen hydrolysate. People with a body weight of 75 kg daily intake of 3 g as extra has proven beneficial. A wide range of the content/concentration of the components ensures maximum protection against copy cats and adjustment to species (humans as well as other mammals i.e. cat, dog, horse, camel) specific requirements!
An advantageous composition of the drug or dietary supplement has 60-92 wt % collagen hydrolyzate, 1-10 wt % free hydroxyproline, 5-20 wt % glucosamine and 2-10 wt % by weight chondroitin, but preferably 80-92% by weight collagen hydrolyzate, 1-5 wt% free hydroxyproline, 5-10 wt% glucosamine and 2-5 wt% chondroitin.